<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Self-Paced Learning for Images of Antinuclear Antibodies - Health AI Hub</title>
    <meta name="description" content="This paper introduces a novel deep learning framework for the automated detection of Antinuclear Antibodies (ANA) from microscope images, a crucial but complex ">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Self-Paced Learning for Images of Antinuclear Antibodies</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.21519v1" target="_blank">2511.21519v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-26
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Yiyang Jiang, Guangwu Qian, Jiaxin Wu, Qi Huang, Qing Li, Yongkang Wu, Xiao-Yong Wei
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.21519v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.21519v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a novel deep learning framework for the automated detection of Antinuclear Antibodies (ANA) from microscope images, a crucial but complex task in diagnosing autoimmune disorders. Addressing the multi-instance, multi-label (MIML) nature of ANA patterns, the framework employs an instance sampler, a probabilistic pseudo-label dispatcher, and self-paced learning to process unaltered images end-to-end. It significantly outperforms prior methods on ANA datasets and general medical MIML benchmarks, setting new state-of-the-art results.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Automated ANA detection is critical for improving the efficiency and accuracy of diagnosing autoimmune disorders like lupus and scleroderma. This research offers a machine learning solution that can reduce the heavy workload, training requirements, and subjectivity inherent in manual ANA assessment, potentially leading to faster and more consistent patient diagnoses.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application automates and enhances the detection of Antinuclear Antibodies (ANA) from fluorescent microscope images, which is critical for diagnosing autoimmune disorders. It uses a multi-instance, multi-label (MIML) deep learning framework to process complex patterns in these images, aiming to improve diagnostic accuracy and efficiency in clinical settings, thereby reducing the need for extensive manual labor and specialized training.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Antinuclear Antibody (ANA) testing is vital for diagnosing autoimmune disorders (e.g., lupus, Sj√∂gren's), but current manual detection is slow, labor-intensive, and demands extensive training due to over 100 antibody types and complex pattern combinations.</li>
                    
                    <li>The problem is framed as a Multi-Instance, Multi-Label (MIML) learning task, where microscope images contain multiple instances (cells/regions) with multiple associated labels (ANA patterns).</li>
                    
                    <li>A novel end-to-end framework is proposed that processes unaltered microscope images without manual preprocessing, inspired by human labeling logic of identifying consistent sub-regions and aggregating labels.</li>
                    
                    <li>The framework comprises three core components: an 'instance sampler' to suppress low-confidence instances by modeling pattern confidence; a 'probabilistic pseudo-label dispatcher' for adaptive label assignment based on instance distinguishability; and 'self-paced weight learning rate coefficients' to adjust training based on empirical label observations.</li>
                    
                    <li>On an ANA dataset, the model achieved significant performance gains of up to +7.0% F1-Macro and +12.6% mAP over the best prior method, establishing new state-of-the-art results.</li>
                    
                    <li>Evaluations on three public medical MIML benchmarks demonstrated the framework's superior generalization, ranking top-2 across all key metrics and reducing Hamming loss by up to 18.2% and one-error by up to 26.9%.</li>
                    
                    <li>The proposed method overcomes limitations of traditional MIML approaches by enabling end-to-end optimization and effectively managing the complexities of real-world ANA detection.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The proposed methodology is a novel deep learning framework designed for Multi-Instance, Multi-Label (MIML) tasks, specifically applied to Antinuclear Antibody (ANA) detection. It operates end-to-end on unaltered microscope images. Key components include an 'instance sampler' that filters low-confidence instances based on pattern confidence, a 'probabilistic pseudo-label dispatcher' for adaptive label assignment guided by instance distinguishability, and 'self-paced weight learning rate coefficients' to dynamically adjust the training process using empirical label observations. This architecture is inspired by human expert logic for identifying and aggregating consistent sub-region patterns.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The framework achieved state-of-the-art results on the ANA dataset, demonstrating improvements of up to +7.0% in F1-Macro score and +12.6% in mean Average Precision (mAP) compared to the previous best method. Furthermore, on three public medical MIML benchmarks, the model ranked among the top-2 across all key metrics, significantly reducing Hamming loss by up to 18.2% and one-error by up to 26.9%, showcasing its robust performance and generalization capabilities.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This technology has the potential to significantly streamline and standardize ANA testing in clinical laboratories. By automating the detection of complex ANA patterns, it can reduce the turnaround time for test results, decrease the reliance on highly trained and scarce experts, and minimize inter-observer variability. This could lead to earlier, more accurate, and more accessible diagnoses of severe autoimmune diseases such as lupus, Sj√∂gren's syndrome, and scleroderma, ultimately improving patient care.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state specific limitations of the proposed framework itself. It only mentions that the framework 'overcomes limitations of traditional MIML methods', implying it addresses previous challenges without introducing new, specific ones for its own design.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly mention future research directions for this specific work.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Immunology</span>
                    
                    <span class="tag">Rheumatology</span>
                    
                    <span class="tag">Pathology</span>
                    
                    <span class="tag">Laboratory Medicine</span>
                    
                    <span class="tag">Clinical Diagnostics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Antinuclear Antibodies (ANA)</span>
                    
                    <span class="tag tag-keyword">Autoimmune Disorders</span>
                    
                    <span class="tag tag-keyword">Deep Learning</span>
                    
                    <span class="tag tag-keyword">Multi-Instance Multi-Label (MIML)</span>
                    
                    <span class="tag tag-keyword">Self-Paced Learning</span>
                    
                    <span class="tag tag-keyword">Medical Imaging</span>
                    
                    <span class="tag tag-keyword">Clinical Diagnostics</span>
                    
                    <span class="tag tag-keyword">Fluorescent Pattern Recognition</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Antinuclear antibody (ANA) testing is a crucial method for diagnosing autoimmune disorders, including lupus, Sj√∂gren's syndrome, and scleroderma. Despite its importance, manual ANA detection is slow, labor-intensive, and demands years of training. ANA detection is complicated by over 100 coexisting antibody types, resulting in vast fluorescent pattern combinations. Although machine learning and deep learning have enabled automation, ANA detection in real-world clinical settings presents unique challenges as it involves multi-instance, multi-label (MIML) learning. In this paper, a novel framework for ANA detection is proposed that handles the complexities of MIML tasks using unaltered microscope images without manual preprocessing. Inspired by human labeling logic, it identifies consistent ANA sub-regions and assigns aggregated labels accordingly. These steps are implemented using three task-specific components: an instance sampler, a probabilistic pseudo-label dispatcher, and self-paced weight learning rate coefficients. The instance sampler suppresses low-confidence instances by modeling pattern confidence, while the dispatcher adaptively assigns labels based on instance distinguishability. Self-paced learning adjusts training according to empirical label observations. Our framework overcomes limitations of traditional MIML methods and supports end-to-end optimization. Extensive experiments on one ANA dataset and three public medical MIML benchmarks demonstrate the superiority of our framework. On the ANA dataset, our model achieves up to +7.0% F1-Macro and +12.6% mAP gains over the best prior method, setting new state-of-the-art results. It also ranks top-2 across all key metrics on public datasets, reducing Hamming loss and one-error by up to 18.2% and 26.9%, respectively. The source code can be accessed at https://github.com/fletcherjiang/ANA-SelfPacedLearning.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>IEEE Transactions on Medical Imaging</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>